This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Liminal Biosciences Limited. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: The Innovations of Alexandre Larivée
Introduction
Alexandre Larivée is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific biological pathways.
Latest Patents
Larivée holds a patent for "GPR84 antagonists and uses thereof." This invention provides compounds and compositions that inhibit GPR84, which is crucial for the treatment of GPR84-mediated disorders. His work in this area showcases his commitment to advancing therapeutic options for various health conditions.
Career Highlights
Throughout his career, Alexandre Larivée has been associated with Liminal Biosciences Limited, where he has played a pivotal role in research and development. His expertise in medicinal chemistry has been instrumental in driving innovative projects within the company.
Collaborations
Larivée has collaborated with talented individuals such as Shaun Abbott and Mylène De Léséleuc. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions.
Conclusion
Alexandre Larivée's contributions to the field of medicinal chemistry, particularly through his patent on GPR84 antagonists, highlight his innovative spirit and dedication to improving healthcare. His work continues to inspire future advancements in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile